hGM－CSF基因及其调控研究进展

人粒细胞－巨噬细胞集落刺激因子基因表达受到转录调控与转录后调控。５＇非转录区的一些顺式调控成分,如ＣＡＴＴ（Ａ／Ｔ）重复序列,富含ＧＣ序列,ＣＫ－１、ＣＫ－２、ｋＢ特异序列与可诱导的ＣｓＡ敏感增强子成分等在转录水平上调控ｈＧＭ－ＣＳＦ的表达。３＇非翻译区有一６２ｂｐ富含ＡＵ序列,这与ｍＲＮＡ的稳定性相关,在翻译水平调控ｈＧＭ－ＣＳＦ的表达,细胞因子与一些刺激因子通过不同的机制作用于ｈＧＭ－ＣＳＦ基     

RNA结合蛋白与巨噬细胞炎症因子表达

RNA结合蛋白(RNA-binding proteins, RBPs)是转录后基因表达的关键调控因子,参与剪接、出核、翻译和稳定性等RNA代谢调控。RBPs表达或功能异常可导致炎症性疾病、代谢性疾病以及神经系统疾病等多种疾病的发生发展。炎症是机体对外界刺激及损伤的防御性免疫反应。巨噬细胞作为机体重要的免疫细胞,通过快速响应刺激并且释放大量炎症因子,进而调控炎症反应。巨噬细胞中炎症因子的表达受到转录以及转录后水平的调控。其中,RBPs参与大量RNA的转录后调控过程。研究发现,一方面,RBPs直接结合炎症因子mRNA中的顺式作用元件,参与其mRNA稳定性和翻译等过程,例如TTP(tristetraprolin);另一方面,某些RBPs通过参与炎症信号通路中一些关键基因mRNA的稳定性、翻译或选择性剪接调控,进而间接影响炎症因子表达及分泌。例如,剪接因子3A亚基1(splicing factor 3A subunit 1, SF3A1)。本文主要总结RBPs在mRNA稳定性、翻译和选择性剪接不同转录后水平调控巨噬细胞炎症因子表达的作用机制。这些RBPs从不同的层面直接或者间接参与调控炎症因子...     

人SDCT2β3'-非翻译区基因表达负调控序列对mRNA稳定性的影响

为探索人高亲和力钠离子依赖性二羧酸转运蛋白基因(high affinity sodium-dependent dicarboxylate transporter,SDCT2)3'端非翻译区是否在基因表达调控中起作用,首先通过生物信息学分析发现,在SDCT2β mRNA的3'端非翻译区内存在585 nt的Au富含区(AU-rich region,AUR),其中包括3个AU富含元件(AU-rich element,ARE),然后将SDCT213的AU富含区DNA片段插入报告基因GFP表达载体pcDNA-GFP的下游,构建pcDNA-GFP-AUR表达载体并转染HEK293、HKC和LLC-PK1细胞系,用Western blot和流式细胞仪检测细胞中GFP的表达水平.结果显示,SDCT2β的AU富含区序列可显著降低GFP的表达水平(P＜0.01).利用放线菌素D阻断RNA转录后,每隔2 h从稳定转染的HEK293细胞中提取总RNA,用RNA印迹分析GFP mRNA的稳定性.结果显示GFP-AUR mRNA较GFP mRNA不稳定.这些结果提示,在SDCT2β3'非翻译区的AU富含区内存在基因表达负调控区,该区可降低mRNA的稳定性、促进mRNA的降解,从而在转录后水平调控基因的表达.     

PI3KγmRNA 3′非翻译区可能存在基因表达负调控区

为探索人磷脂酰肌醇 3 激酶γ(phosphoinositide 3 kinasePI3Kγ)基因 3′端非翻译区内AU富含区是否在基因表达调控中起作用 ,首先通过生物信息学分析发现在其 3′端非翻译区 (UTR)内存在0 9kb的AU富含区 ,其中包括 4个AU富含元件 ,以及 1个与众多基因非翻译区高度同源的长 130个碱基的区域 .将AU富含区插入报告基因egfp的下游构建pcDNA3 egfp AUR表达载体 .将表达载体转导NIH 3T3,74 0 2及K5 6 2细胞 ,流式细胞检测egfp的表达情况 .PI3Kγ基因 3′非翻译区AU富含区可显著降低egfp的表达 2～ 3倍 (P <0 0 1) .利用放线菌素D阻断RNA转录后 ,Northern印迹分析结果显示egfp AURmRNA较egfpmRNA不稳定 .实验结果提示 ,PI3Kγ基因 3′非翻译区AU富含区内可能存在转录后水平的基因表达负调控区 ,该负调控区可在一定程度上加速mRNA的衰变     

PI3KγmRNA 3′非翻译区可能存在基因表达负调控区

为探索人磷脂酰肌醇 3 激酶γ(phosphoinositide 3 kinasePI3Kγ)基因 3′端非翻译区内AU富含区是否在基因表达调控中起作用 ,首先通过生物信息学分析发现在其 3′端非翻译区 (UTR)内存在0 9kb的AU富含区 ,其中包括 4个AU富含元件 ,以及 1个与众多基因非翻译区高度同源的长 130个碱基的区域 .将AU富含区插入报告基因egfp的下游构建pcDNA3 egfp AUR表达载体 .将表达载体转导NIH 3T3,74 0 2及K5 6 2细胞 ,流式细胞检测egfp的表达情况 .PI3Kγ基因 3′非翻译区AU富含区可显著降低egfp的表达 2～ 3倍 (P <0 0 1) .利用放线菌素D阻断RNA转录后 ,Northern印迹分析结果显示egfp AURmRNA较egfpmRNA不稳定 .实验结果提示 ,PI3Kγ基因 3′非翻译区AU富含区内可能存在转录后水平的基因表达负调控区 ,该负调控区可在一定程度上加速mRNA的衰变     

基因表达与mRNA结构的关系

基因的转录调控和转录后水平的调控在基因表达过程中起着重要作用。mRNA的结构与基因表达调控的关系非常密切。目前对于mRNA结构对表达的影响因素,主要集中于起始密码子和S-D序列的结构和间隔长度、基因和基因间的间隔区序列和长度,5’末端与3’末端非翻译区、多聚（A）尾、内含子序列对翻译起始效率、发夹结构对mRNA的稳定性的影响和mRNA翻译起始区等对基因表达影响。     

人SDCT2β 3′-非翻译区基因表达负调控序列对mRNA稳定性的影响

为探索人高亲和力钠离子依赖性二羧酸转运蛋白基因（high affinity sodium-dependent dicarboxylate transporter,SDCT2）3′端非翻译区是否在基因表达调控中起作用,首先通过生物信息学分析发现,在SDCT2βmRNA的3′端非翻译区内存在585nt的AU富含区（AU-rich region,AUR）,其中包括3个AU富含元件（AU-rich element,ARE）,然后将SDCT2β的AU富含区DNA片段插入报告基因GFP表达载体pcDNA-GFP的下游,构建pcDNA-GFP-AUR表达载体并转染HEK293、HKC和LLC-PK1细胞系,用Western blot和流式细胞仪检测细胞中GFP的表达水平.结果显示,SDCT2β的AU富含区序列可显著降低GFP的表达水平（P〈0.01）.利用放线菌素D阻断RNA转录后,每隔2h从稳定转染的HEK293细胞中提取总RNA,用RNA印迹分析GFP mRNA的稳定性.结果显示GFP-AURmRNA较GFP mRNA不稳定.这些结果提示,在SDCT2β3′非翻译区的AU富含区内存在基因表达负调控区,该区可降低mRNA的稳定性、促进mRNA的降解,从而在转录后水平调控基因的表达.     

人类基因组miRNA转录调控区保守性DNA序列生物信息学分析

MicroRNA(miPNA)的表达调控方式一直是一个有争议的问题,为了研究miRNA潜在的转录调控特点,本文通过Sanger网站miRNA数据库获得人类miRNA的信息,并建立miRNA相关信息数据库,用MEME和Wordspy两个软件对其上游2 000 bp序列进行保守性分析,得到保守性的DNA序YU(motif),用TESS软件分析保守性DNA序列,预测其转录因子结合情况.通过比较位于基因间、反义链和内含子中的三类不同miRNA转录调控区的保守性和自主转录能力的差异,结果发现位于基因间、反义链上的miRNA上游调控区的保守性比位于内含子的miRNA高,在miRNA的转录调控区存在RNA聚合酶Ⅱ类型的转录因子结合位点,miRNA还表现出自身独特的转录调控方式.通过分析,我们还得到了miRNA表达调控中一些重要的转录因子以及独特的调控序列.本研究结果为miRNA转录调控机制的进一步研究提供了理论依据.     

酵母基因上游序列中潜在的转录正调控位点分析

前期研究表明,高效转录酵母基因内含子在序列长度、寡核苷酸使用、以及位置分布等方面都有着区别于低转录内含子的特征 . 进一步观察发现：上游基因间区域的序列长度与基因转录频率也有与内含子序列相同的现象,转录频率高的上游基因间序列一般都比转录频率低的长 . 对高效转录和低效转录上游基因间序列的寡核苷酸使用频率进行统计比较分析,抽提出高转录基因上游区可能的转录正调控元件 . 与酵母的所有非编码序列比较,这些可能的正调控元件基本上也是过表达的 (over-represented) ,其中多数和实验所得的一些位点特征相吻合 . 这些元件富含 G 、 C ,这与内含子中可能的正调控元件在碱基组成上有一定的互补性 . 从这些特征看,高效转录基因上游的序列结构确实有利于基因的转录 .     

应用系统遗传学与细胞发生的基因调控网络序列标记显示分析

基因型-表现型复杂系统自组织化是基因系统到蛋白质系统、代谢酶系统的遗传信息转换过程。一个协同表达的基因群调控一个相对独立性状的功能模块,基因网络的自组织化建构基因组稳态与遗传适应过程。腺垂体干细胞分化成5种不同的内分泌细胞系,受上丘脑和性腺、胰岛细胞等激素的调控,涉及系列转录因子的诱导表达,成为细胞系发生研究的模型。GH基因的表达受上丘脑激素GRF、GHRP-6刺激以及SMS抑制,经不同受体、G蛋白亚单元和PKA、PKC信号传导路径,转录因子调控细胞再生或GH基因表达、激素分泌。基因表达调控决定于基因序列,如启动子、非翻译RNA区、蛋白质的结构域等,系统生物学包括组学、计算与合成生物技术,序列标志片段显示(STFD),可用于细胞系分化、病理变化等基因表达谱、信号传导网络的系统分析与功能基因克隆。     

hGM-CSF基因穿梭表达载体的构建及其在鱼腥藻7120中的克隆

人粒-巨噬细胞集落刺激因子(hGM-CSF)作为一种造血生长因子,能够刺激T细胞和巨噬细胞增殖、成熟和分化,具有极其重要的免疫调解功能.本研究运用PCR方法,从质粒pAG-MT-8中克隆该基因,并在其5′端添加有利于在蓝藻细胞中高效表达的SD序列,然后插入到表达载体(pRL-439)强启动子PpsbA的下游,进一步与穿梭表达载体pDC-08相连构建成穿梭表达载体pDC-GM.利用三亲接合转移方法将该穿梭表达载体(pDC-GM)转入丝状鱼腥藻7120,通过相应抗生素筛选后得到能稳定遗传的转基因藻.以该转基因藻的基因组DNA为模板进行PCR检测,结果表明hGM-CSF基因已转入鱼腥藻7120.这是首次尝试把蓝藻作为制备重组hGM-CSF的新宿主,具有潜在的经济价值和社会效益.     

The molecular biology of the colony-stimulating factors

Our understanding of the biochemistry and molecular biology of the colony stimulating factors (CSF) and the regulation of their production has advanced rapidly with the application of recombinant DNA technology. This report reviews several aspects of the regulation of CSF production and the structural features relating to their function. The structural gene for hGM-CSF is present as a single copy, is 2.5 kilobase long region and is located on the long arm of chromosome 5. The genes for human multi-CSF and M-CSF are also on chromosome 5. The gene for hGM-CSF is organized into four exons. The intron-exon boundaries contain a single consensus splice donor and acceptor sequence. CSFs are elaborated by endothelial cells, fibroblasts, and T lymphocytes in response to inflammatory mediators. Many of these same cell types respond to inflammatory stimuli with production of additional immune mediators such as IL-1, IL-2, or the interferons. Insights are now emerging into important structure--function relationships of the hematopoietic growth factors and molecular events in the regulation of CSF gene expression.     

Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity

Native human granulocyte-macrophage colony stimulating factor (hGM-CSF) has previously been purified using methods which typically required several sequential chromatographic steps and only yielded small amounts of hGM-CSF. We have purified and characterized hGM-CSF using monoclonal antibodies raised against bacterially synthesized hGM-CSF. Activated donor T-lymphocytes grown in interleukin-2 and then reactivated with phytohemagglutinin produce several forms of hGM-CSF which can be purified using immunoaffinity absorption followed by reversed phase high performance liquid chromatography. The purified hGM-CSF consisted of at least nine species ranging in molecular weight (Mr) from 14,500 to 32,000. The higher Mr forms contained one or two N-linked carbohydrate moieties and were more acidic by two-dimensional Western blot analysis, consistent with increasing sialation. N-terminal sequence analysis of high and low molecular weight hGM-CSF fractions corresponded to that predicted by the cDNA sequence. Using the AML 193 [3H]thymidine incorporation assay the specific activity of the heavily glycosylated hGM-CSF was 1 x 10(8) units/mg compared with 6 x 10(8) units/mg for the non-glycosylated hGM-CSF produced by Escherichia coli. The different hGM-CSF forms induced neutrophil superoxide anion production by a variable amount depending on the extent of N-linked glycosylation. Receptor binding studies demonstrated lower receptor affinity for the heavily glycosylated form (KD = 820 pM) compared to less heavily glycosylated (KD = 78 pM) and non-glycosylated hGM-CSF produced by E. coli (KD = 30 pM). These differences are due to differences in the kinetic association rate.     

Modification of the N-Terminal Nucleotide Sequence of Mature hGM-CSF Results in High Expression in the Foreign Host, Anabaena sp. Strain PCC 7120

Cloning and high foreign expression of the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene were achieved in Anabaena sp. strain PCC 7120 cells. To promote high expression of hGM-CSF in cyanobacterial cells, PCR primers were designed to modify the N-terminal cDNA sequence of mature hGM-CSF, including a GC rich region and some discriminating against codons according to the degeneracy codon rules, selecting for prokaryotic usage codons. The PCR product encoding the modified hGM-CSF was inserted downstream of the promoter, PpsbA of the shuttle vector pRL439, then ligated with pDC-08 to generate the shuttle expression plasmid, pDC-GM1. The resulting shuttle expression plasmid was transferred into the filamentous, heterocyst-forming cyanobacterium, Anabaena sp. strain PCC 7120 using the tri-parental conjugation transfer method. The results of PCR amplification of wild type and transgenic cells indicated that the hGM-CSF gene was successfully cloned into Anabaena sp. strain PCC 7120 cells. Western blot analysis showed that the protein expression of modified hGM-CSF in transgenic cells harboring pDC-GM1 was 136% higher than that of non-modified hGM-CSF in transgenic cells harboring pDC-GM0. Additionally, there were similar rate of growth and content of Chl a as compared to controls, suggesting that foreign hGM-CSF did not impair the photosynthetic activity of host cells. Taken together, the results indicate that modification of the N-terminal nucleotide sequence of mature hGM-CSF results in high expression in the transgenic cells.     

Production and characterization of human granulocyte–macrophage colony-stimulating factor (hGM-CSF) expressed in the oleaginous yeast Yarrowia lipolytica

Since its isolation, the human granulocyte-macrophage colony-stimulating factor (hGM-CSF) has been proposed as a new class of therapeutic biological products in the treatment of various diseases. However, the toxicity of this cytokine towards its expression host constitutes a major obstacle to bioprocess development for large-scale production. In this work, the optimized gene encoding hGM-CSF was expressed in the yeast Yarrowia lipolytica in one and two copies under the control of the fatty acid-inducible POX2 promoter. Protein secretion was directed by the targeting sequence of the extracellular lipase (LIP2): preXALip2. After 48?h of induction, Western blot analysis revealed the presence of a nonglycosylated form of 14.5?kDa and a trail of hGM-CSF hyperglycosylated varying from 23?kDa to more than 60?kDa. The two-copy transformants produced hGM-CSF level which was sevenfold higher compared to the single-copy ones. Deglycosylation with PNGase F showed two forms: a mature form of 14.5?kDa and an unprocessed form of 18?kDa. The addition of two alanines to the signal sequence resulted in correct hGM-CSF processing. The production level was estimated at 250?mg/l after preliminary optimization studies of the cultivation and induction phases. The purified hGM-CSF was identified by N-terminal sequencing and LC-MS/MS analysis; its biological activity was confirmed by stimulating the proliferation of TF1 cell line. This study demonstrated that Y. lipolytica is a promising host for the efficient production of active toxic proteins like hGM-CSF.     

优化mRNA翻译起始区提高人粒－巨噬细胞集落刺激因子在E．coli中的表达

人粒－巨噬细胞集落刺激因子（ｈＧＭ－ＣＳＦ）是一种重要的造血生长因子．利用基因重组技术构建两个ｈＧＭ－ＣＳＦ的Ｅ．ｃｏｌｉ表达菌株,一个为在不改变氨基酸顺序的前提下,对ｍＲＮＡ翻译起始区核苷酸顺序进行优化突变（ｈＧＭ－ＣＳＦ（Ｍ））,另一个为未突变的对照（ｈＧＭ－ＣＳＦ（Ｎ））．经酶切电泳、ＤＮＡ测序、ＳＤＳ－ＰＡＧＥ和Ｗｅｓｔｅｒｎｂｌｏｔ等分析鉴定,证明两者均能表达特异性的１４．６ｋＤｈＧＭ－ＣＳＦ,但ｈＧＭ－ＣＳＦ（Ｍ）的表达水平较ｈＧＭ－ＣＳＦ（Ｎ）提高了１．２６倍,占菌体总蛋白的１６．９％．ｍＲＮＡ翻译起始区二级结构预测分析表明,优化突变后生成自由能ΔＧ从原来的－１０．２提高至－９．４Ｋｃａｌ,ＡＵＧ从部分配对状态变为非配对状态．     

A sequence-specific single-strand DNA binding protein that contacts repressor sequences in the human GM-CSF promoter.

NF-GMb is a nuclear factor that binds to the proximal promoter of the human granulocyte-macrophage colony stimulating factor (GM-CSF) gene. NF-GMb has a subunit molecular weight of 22 kDa, is constitutively expressed in embryonic fibroblasts and binds to sequences within the adjacent CK-1 and CK-2 elements (CK-1/CK-2 region), located at approximately -100 in the GM-CSF gene promoter. These elements are conserved in haemopoietic growth factor (HGF) genes. NF-GMb binding requires the presence of repeated 5'CAGG3' sequences that overlap the binding sites for positive activators. Surprisingly, NF-GMb was found to bind solely to single-strand DNA, namely the non-coding strand of the GM-CSF CK-1/CK-2 region. NF-GMb may belong to a family of single-strand DNA binding (ssdb) proteins that have 5'CAGG3' sequences within their binding sites. Functional analysis of the proximal GM-CSF promoter revealed that sequences in the -114 to -79 region of the promoter containing the NF-GMb binding sites had no intrinsic activity in fibroblasts but could, however, repress tumour necrosis factor-alpha (TNF-alpha) inducible expression directed by downstream promoter sequences (-65 to -31). Subsequent mutation analysis showed that sequences involved in repression correlated with those required for NF-GMb binding.     

High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture

Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) has been previously produced in tobacco cell suspension cultures. However, the amount of hGM-CSF accumulated in the culture medium dropped quickly from its maximum of 150 microg/L at 5 d after incubation. To overcome this problem, we sought an expression system in which heterologous gene expression could be induced at high levels. We selected a rice amylase expression system in which the promoter Ramy3D is induced to express recombinant protein by sucrose starvation. This induction system was found to give good yield of recombinant hGM-CSF in transgenic rice cell suspension culture and protease activity of this culture medium was low compared to that of tobacco culture system.     

Prothymosin alpha is phosphorylated by casein kinase-2.

Prothymosin alpha (ProT alpha) is a 12.5 kDa acidic polypeptide that is considered to have a nuclear function related to cell proliferation. Inspection of its amino acid sequence revealed the presence of sequences that may serve as targets for phosphorylation by casein kinase-2 (CK-2). ProT alpha isolated from calf thymocytes was phosphorylated in vitro by CK-2. The phosphorylation sites are Ser and Thr residues located among the first 14 amino acid residues in the ProT alpha sequence. Another site that is theoretically suitable for phosphorylation by CK-2, at the C-terminus of the polypeptide, is not, in fact, phosphorylated. Thymosin alpha 1 (T alpha 1), a peptide whose sequence corresponds to the first 28 amino acids of ProT alpha, is also phosphorylated by CK-2 at the same phosphorylation sites as ProT alpha. In cultured splenic lymphocytes ProT alpha was phosphorylated at Thr residues located at positions 7, 12 and/or 13. Based on these observations we conclude that CK-2, or another cellular kinase with similar sequence specificity, is responsible for phosphorylation of ProT alpha in vivo.     

Molecular cloning,expression in Escherichia coli and production of bioactive homogeneous recombinant human granulocyte and macrophage colony stimulating factor

Human granulocyte and macrophage colony stimulating factor (hGM-CSF) is a glycoprotein that activates and enhances the differentiation and survival of neutrophils, eosinophils and macrophages, which play a key role in the innate immune response. Here we describe the construction of the hGM-CSF encoding gene, cloning, expression in Escherichia coli, purification of recombinant hGM-CSF, N-terminal amino acid sequencing, and biological activity assay using TF-1 cells. The results presented show that the combination of experimental strategies employed to obtain recombinant hGM-CSF can yield biologically active protein, and may be useful to scaling-up production of biosimilar protein.